ArriVent BioPharma (NASDAQ:AVBP) Downgraded to “Strong Sell” Rating by Wall Street Zen
Wall Street Zen cut shares of ArriVent BioPharma (NASDAQ:AVBP – Free Report) from a hold rating to a strong sell rating in a research report sent to investors on Thursday morning. Several other equities analysts also recently commented on the stock. Jones Trading assumed coverage on shares of ArriVent BioPharma in a report on Tuesday, […]
Wall Street Zen cut shares of ArriVent BioPharma (NASDAQ:AVBP – Free Report) from a hold rating to a strong sell rating in a research report sent to investors on Thursday morning. Several other equities analysts also recently commented on the stock. Jones Trading assumed coverage on shares of ArriVent BioPharma in a report on Tuesday, […]
